MarketPeel
Insider Trading Intelligence
Pricing
…
KE

Karin Eastham

VCYT
DIRECTOR · VERACYTE, INC. · CIK 0001231845
FILING MIX · LIFETIME48%/52%
BUYS
41
SELLS
45
TOTAL VALUE
$151.42M
COMPANIES
4
ACTIVE SINCE
May 2020
HOLDINGS NOW
73,526
AVG SELL PX
$848.67
TRADE KIND
SHOWING 86 / 86
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
29 backtested trades · 8 horizons · 15 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Karin Eastham, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d29+68.97%-2.97%+0.37%-3.34%-3.73%—
14d29+72.41%-6.06%+0.61%-6.67%-7.10%—
30d29+68.97%-5.79%+0.94%-6.73%-2.80%—
60d29+62.07%-4.83%+2.52%-7.35%-15.96%—
90d29+62.07%-8.03%+3.26%-11.29%-9.44%—
180d29+55.17%-6.67%+5.60%-13.87%-30.33%—
1y29(4 pending)+64.00%-20.77%+8.01%-28.78%-33.95%—
2y29(11 pending)+72.22%-17.57%+15.03%-32.60%-53.74%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
VCYT · 15,626 shares · as of Jun 18, 2026
010,78121,56332,34443,125202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 41 buys / 45 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
VCYT
VERACYTE, INC.
SALE10b5-1
10b5-1 plan
3,200$52.78$168.9K15,626Jun 18, 2026Jun 22, 2026 ↗View →
VCYT
VERACYTE, INC.
SALE10b5-1
10b5-1 plan
529$53.55$28.3K15,097Jun 18, 2026Jun 22, 2026 ↗View →
VCYT
VERACYTE, INC.
PURCHASEGRANT
Stock grant
5,272——18,826Jun 11, 2026Jun 15, 2026 ↗View →
PSNL
PERSONALIS, INC.
PURCHASEGRANT
Stock grant
37,500——37,500May 12, 2026May 14, 2026 ↗View →
PSNL
PERSONALIS, INC.
PURCHASEGRANT
Stock grant
6,250——22,366May 12, 2026May 14, 2026 ↗View →
PSNL
PERSONALIS, INC.
PURCHASEGRANT
Stock grant
6,250——19,756May 12, 2026Jun 11, 2026 ↗View →
VCYT
VERACYTE, INC.
SALE
10,000——0Dec 5, 2025Dec 8, 2025 ↗View →
VCYT
VERACYTE, INC.
PURCHASE
10,000$7.94$79.4K23,554Dec 5, 2025Dec 8, 2025 ↗View →
VCYT
VERACYTE, INC.
PURCHASE
10,000$7.60$76.0K33,554Dec 5, 2025Dec 8, 2025 ↗View →
VCYT
VERACYTE, INC.
SALE10b5-1
10b5-1 plan
6,392$44.52$284.6K27,162Dec 5, 2025Dec 8, 2025 ↗View →
VCYT
VERACYTE, INC.
SALE10b5-1
10b5-1 plan
800$46.59$37.3K13,554Dec 5, 2025Dec 8, 2025 ↗View →
VCYT
VERACYTE, INC.
SALE10b5-1
10b5-1 plan
12,808$45.84$587.1K14,354Dec 5, 2025Dec 8, 2025 ↗View →
VCYT
VERACYTE, INC.
SALE10b5-1
10b5-1 plan
9,674$40.02$387.2K13,554Nov 5, 2025Nov 7, 2025 ↗View →
VCYT
VERACYTE, INC.
PURCHASEGRANT
Stock grant
9,321——23,228Jun 18, 2025Jun 23, 2025 ↗View →
VCYT
VERACYTE, INC.
SALE10b5-1
10b5-1 plan
4,590$26.66$122.4K13,907Jun 13, 2025Jun 17, 2025 ↗View →
PSNL
PERSONALIS, INC.
PURCHASEGRANT
Stock grant
50,000——50,000May 16, 2025May 20, 2025 ↗View →
VCYT
VERACYTE, INC.
PURCHASE
10,000$5.28$52.8K28,497Jan 2, 2025Jan 6, 2025 ↗View →
VCYT
VERACYTE, INC.
SALE10b5-1
10b5-1 plan
4,691$40.50$190.0K18,497Jan 2, 2025Jan 6, 2025 ↗View →
VCYT
VERACYTE, INC.
SALE10b5-1
10b5-1 plan
5,309$40.12$213.0K23,188Jan 2, 2025Jan 6, 2025 ↗View →
VCYT
VERACYTE, INC.
SALE
10,000——0Jan 2, 2025Jan 6, 2025 ↗View →
VCYT
VERACYTE, INC.
SALE10b5-1
10b5-1 plan
3,006$37.77$113.5K28,622Nov 19, 2024Nov 21, 2024 ↗View →
VCYT
VERACYTE, INC.
SALE10b5-1
10b5-1 plan
1,600$36.77$58.8K31,628Nov 19, 2024Nov 21, 2024 ↗View →
VCYT
VERACYTE, INC.
SALE10b5-1
10b5-1 plan
10,125$38.76$392.4K18,497Nov 19, 2024Nov 21, 2024 ↗View →
VCYT
VERACYTE, INC.
SALE10b5-1
10b5-1 plan
7,500$25.00$187.5K33,228Jul 16, 2024Jul 18, 2024 ↗View →
VCYT
VERACYTE, INC.
PURCHASEGRANT
Stock grant
11,473——40,728Jun 13, 2024Jun 17, 2024 ↗View →
VCYT
VERACYTE, INC.
SALE10b5-1
10b5-1 plan
3,870$20.59$79.7K29,255Jun 11, 2024Jun 13, 2024 ↗View →
VCYT
VERACYTE, INC.
PURCHASE
2,500$10.41$26.0K35,625Jun 7, 2024Jun 11, 2024 ↗View →
VCYT
VERACYTE, INC.
SALE
2,500——7,500Jun 7, 2024Jun 11, 2024 ↗View →
VCYT
VERACYTE, INC.
SALE10b5-1
10b5-1 plan
2,500$20.97$52.4K33,125Jun 7, 2024Jun 11, 2024 ↗View →
PSNL
PERSONALIS, INC.
PURCHASEGRANT
Stock grant
50,000——50,000May 17, 2024May 21, 2024 ↗View →
VCYT
VERACYTE, INC.
SALE
10,000$13.19$131.9K0Apr 1, 2024Apr 2, 2024 ↗View →
VCYT
VERACYTE, INC.
PURCHASE
10,000$13.19$131.9K43,125Apr 1, 2024Apr 2, 2024 ↗View →
VCYT
VERACYTE, INC.
SALE
10,000$21.65$216.5K33,125Apr 1, 2024Apr 2, 2024 ↗View →
VCYT
VERACYTE, INC.
PURCHASEGRANT
Stock grant
9,674——33,125Jun 9, 2023Jun 13, 2023 ↗View →
PSNL
PERSONALIS, INC.
PURCHASEGRANT
Stock grant
40,000——40,000May 17, 2023May 19, 2023 ↗View →
VCYT
VERACYTE, INC.
PURCHASE
18,750$12.12$227.3K42,201Mar 16, 2023Mar 17, 2023 ↗View →
VCYT
VERACYTE, INC.
SALE
18,750——0Mar 16, 2023Mar 17, 2023 ↗View →
VCYT
VERACYTE, INC.
SALE
18,750$22.78$427.0K23,451Mar 16, 2023Mar 17, 2023 ↗View →
VCYT
VERACYTE, INC.
SALE
10,000$25.00$250.0K23,451Feb 28, 2023Mar 2, 2023 ↗View →
VCYT
VERACYTE, INC.
SALE
10,000——18,750Feb 28, 2023Mar 2, 2023 ↗View →
VCYT
VERACYTE, INC.
PURCHASE
10,000$12.12$121.2K33,451Feb 28, 2023Mar 2, 2023 ↗View →
GERN
GERON CORP
PURCHASE
35,000$1.10$38.5K109,047Jan 13, 2023Jan 17, 2023 ↗View →
GERN
GERON CORP
SALE
35,000——0Jan 13, 2023Jan 17, 2023 ↗View →
NKTR
NEKTAR THERAPEUTICS
PURCHASEGRANT
Stock grant
10,200——23,233Sep 16, 2022Sep 20, 2022 ↗View →
NKTR
NEKTAR THERAPEUTICS
PURCHASEGRANT
Stock grant
20,400——20,400Sep 16, 2022Sep 20, 2022 ↗View →
NKTR
NEKTAR THERAPEUTICS
SALE
21,267$3.61$76.8K13,033Sep 13, 2022Sep 14, 2022 ↗View →
VCYT
VERACYTE, INC.
PURCHASEGRANT
Stock grant
14,731——23,451Jun 16, 2022Jun 16, 2022 ↗View →
PSNL
PERSONALIS, INC.
PURCHASEGRANT
Stock grant
15,035——15,035May 17, 2022May 19, 2022 ↗View →
PSNL
PERSONALIS, INC.
PURCHASEGRANT
Stock grant
10,770——13,506May 17, 2022May 19, 2022 ↗View →
GERN
GERON CORP
PURCHASEGRANT
Stock grant
125,000——125,000May 10, 2022May 11, 2022 ↗View →
GERN
GERON CORP
PURCHASE
35,000$1.41$49.4K74,047Apr 20, 2022Apr 21, 2022 ↗View →
GERN
GERON CORP
SALE
35,000——0Apr 20, 2022Apr 21, 2022 ↗View →
VCYT
VERACYTE, INC.
PURCHASE
5,000$12.12$60.6K13,720Dec 17, 2021Dec 20, 2021 ↗View →
VCYT
VERACYTE, INC.
SALE
5,000——28,750Dec 17, 2021Dec 20, 2021 ↗View →
VCYT
VERACYTE, INC.
SALE
5,000$45.00$225.0K8,720Dec 17, 2021Dec 20, 2021 ↗View →
VCYT
VERACYTE, INC.
SALE
2,959$49,015.00$145.04M1,241Nov 1, 2021Nov 3, 2021 ↗View →
VCYT
VERACYTE, INC.
SALE
1,241$49.48$61.4K0Nov 1, 2021Nov 3, 2021 ↗View →
VCYT
VERACYTE, INC.
SALE
200$47.73$9.5K4,200Nov 1, 2021Nov 3, 2021 ↗View →
NKTR
NEKTAR THERAPEUTICS
PURCHASEGRANT
Stock grant
10,200——34,300Sep 22, 2021Sep 24, 2021 ↗View →
NKTR
NEKTAR THERAPEUTICS
PURCHASEGRANT
Stock grant
20,400——20,400Sep 22, 2021Sep 24, 2021 ↗View →
VCYT
VERACYTE, INC.
SALE
2,846$43.54$123.9K5,954Aug 2, 2021Aug 4, 2021 ↗View →
VCYT
VERACYTE, INC.
SALE
1,554$44.57$69.3K4,400Aug 2, 2021Aug 4, 2021 ↗View →
VCYT
VERACYTE, INC.
PURCHASEGRANT
Stock grant
8,720——8,720Jun 8, 2021Jun 10, 2021 ↗View →
PSNL
PERSONALIS, INC.
PURCHASEGRANT
Stock grant
4,229——4,229May 14, 2021May 18, 2021 ↗View →
PSNL
PERSONALIS, INC.
PURCHASEGRANT
Stock grant
2,736——2,736May 14, 2021May 18, 2021 ↗View →
GERN
GERON CORP
PURCHASEGRANT
Stock grant
83,000——83,000May 11, 2021May 13, 2021 ↗View →
VCYT
VERACYTE, INC.
SALE
3,527$48.01$169.3K9,700May 3, 2021May 5, 2021 ↗View →
VCYT
VERACYTE, INC.
SALE
250$50.03$12.5K8,800May 3, 2021May 5, 2021 ↗View →
VCYT
VERACYTE, INC.
SALE
650$49.00$31.8K9,050May 3, 2021May 5, 2021 ↗View →
VCYT
VERACYTE, INC.
SALE
6,250——0Feb 25, 2021May 5, 2021 ↗View →
VCYT
VERACYTE, INC.
SALE
200$61.77$12.4K0Feb 25, 2021May 5, 2021 ↗View →
VCYT
VERACYTE, INC.
PURCHASE
6,250$4.00$25.0K6,250Feb 25, 2021May 5, 2021 ↗View →
VCYT
VERACYTE, INC.
SALE
3,606$61.09$220.3K200Feb 25, 2021May 5, 2021 ↗View →
VCYT
VERACYTE, INC.
SALE
2,444$60.03$146.7K3,806Feb 25, 2021May 5, 2021 ↗View →
VCYT
VERACYTE, INC.
SALE
3,606$61.09$220.3K200Feb 25, 2021Feb 26, 2021 ↗View →
VCYT
VERACYTE, INC.
PURCHASE
6,250$4.00$25.0K6,250Feb 25, 2021Feb 26, 2021 ↗View →
VCYT
VERACYTE, INC.
SALE
2,444$60.03$146.7K3,806Feb 25, 2021Feb 26, 2021 ↗View →
VCYT
VERACYTE, INC.
SALE
6,250——0Feb 25, 2021Feb 26, 2021 ↗View →
VCYT
VERACYTE, INC.
SALE
200$61.77$12.4K0Feb 25, 2021Feb 26, 2021 ↗View →
NKTR
NEKTAR THERAPEUTICS
PURCHASEGRANT
Stock grant
18,200——18,200Sep 22, 2020Sep 24, 2020 ↗View →
NKTR
NEKTAR THERAPEUTICS
PURCHASEGRANT
Stock grant
9,100——24,100Sep 22, 2020Sep 24, 2020 ↗View →
NKTR
NEKTAR THERAPEUTICS
PURCHASEGRANT
Stock grant
18,200——18,200Sep 22, 2020Sep 25, 2020 ↗View →
NKTR
NEKTAR THERAPEUTICS
PURCHASEGRANT
Stock grant
9,100——24,100Sep 22, 2020Sep 25, 2020 ↗View →
VCYT
VERACYTE, INC.
PURCHASEGRANT
Stock grant
10,000——10,000Jun 8, 2020Jun 9, 2020 ↗View →
GERN
GERON CORP
PURCHASEGRANT
Stock grant
83,000——83,000Jun 5, 2020Jun 9, 2020 ↗View →
PSNL
PERSONALIS, INC.
PURCHASEGRANT
Stock grant
14,000——14,000May 15, 2020May 19, 2020 ↗View →
Other insiders · VCYT
Loading peer insiders…
About this filer
CIK 0001231845
ROLE
Director
PRIMARY
VCYT
COMPANIES
4
ACTIVE SINCE
May 2020
MARKETPEEL · /INSIDER/0001231845DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback